Nintedanib

Red

Brand Name(s):Ofev

Indication:Idiopathic Pulmonary Fibrosis (IPF).

Rationale:1,2,3

Considered:Mar-15

Review Date:Feb-21

Comments:
NICE technology appraisal guidance [TA347]

Nintedanib, in combination with docetaxel, for previously treated locally advanced, metastatic, or locally recurrent non small cell lung cancer. Full guidance available at: http://www.nice.org.uk/guidance/ta347/resources/guidance-nintedanib-for-previously-treated-locally-advanced-metastatic-or-locally-recurrent-nonsmallcell-lung-cancer-pdf

July 2015